Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10592377 | Bioorganic & Medicinal Chemistry Letters | 2014 | 5 Pages |
Abstract
The design and synthesis of a series of novel tricyclic IAP inhibitors is reported. Rapid assembly of the core tricycle involved two key steps: Rh-catalyzed hydrogenation of an unsaturated bicyclic ring system and a Ru-catalyzed ring closing alkene metathesis reaction. The final Smac mimetics bind to cIAP1 and XIAP BIR3 domains and elicit the desired phenotype in cellular proliferation assays. Dimeric IAP inhibitors were found to possess nanomolar potency in a cellular proliferation assay and favourable in vitro drug-like properties.
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Alexander W. Hird, Brian M. Aquila, Michael H. Block, Edward J. Hennessy, Victor M. Kamhi, Charles A. Omer, Naomi M. Laing, Jamal C. Saeh, Li Sha, Bin Yang,